Federal Register / Vol. 62, No. 44 / Thursday, March 6, 1997 / Notices 10285

ANNUAL BURDEN ESTIMATES—Continued

Instrument Number of

respondents

Number of

responses

per respondent

Average burden hours

per response

Total burden

hours

Estimated total annual burden hours: ............................................................... ...................... ...................... ...................... 3,648

Additional Information: ACF is

requesting that OMB grant a 180 day

approval for this information collection

under procedures for emergency

processing by March 21, 1997. A copy

of this information collection, with

applicable supporting documentation,

may be obtained by calling the

Administration for Children and

Families, Reports Clearance Officer,

Larry Guerrero at (202) 401–6465.

Comments and questions about the

information collection described above

should be directed to the Office of

Information and Regulatory Affairs,

ATTN: OMB Desk Officer for ACF,

Office of Management and Budget,

Paperwork Reduction Project, 725 17th

Street N.W., Washington, D.C. 20503,

(202) 395–7316.

Dated: February 28, 1997.

Bob Sargis,

Acting Reports Clearance Officer.

[FR Doc. 97–5451 Filed 3–5–97; 8:45 am]

BILLING CODE 4184–01–M

Food and Drug Administration

[Docket No. 97G–0063]

Cerestar Holding Co. B.V., Mitsubishi

Chemical Corp., and Nikken Chemicals

Co., Ltd.; Filing of Petition for

Affirmation of GRAS Status

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Cerestar Holding Co. B.V.,

Mitsubishi Chemical Corp., and Nikken

Chemicals Co., Ltd., have filed a

petition (GRASP 7G0422) proposing to

affirm that the use of erythritol is

generally recognized as safe (GRAS) as

an ingredient in human food.

DATES: Written comments by May 20,

1997.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Rosalie M. Angeles, Center for Food

Safety and Applied Nutrition (HFS–

205), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3107.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(secs. 201(s) and 409(b)(5) (21 U.S.C.

321(s) and 348(b)(5)) and the regulations

for affirmation of GRAS status in

§ 170.35 (21 CFR 170.35), notice is given

that Cerestar Holding Co. B.V.,

Mitsubishi Chemical Corp., and Nikken

Chemicals Co., Ltd., c/o Hyman, Phelps

& McNamara, 700 13th St. NW., suite

1200, Washington, DC 20005, have filed

a petition (GRASP 7G0422) proposing

that erythritol be affirmed as GRAS for

use as an ingredient in human food.

The petition has been placed on

display at the Dockets Management

Branch (address above).

Any petition that meets the

requirements outlined in §§ 170.30 (21

CFR 170.30) and 170.35 is filed by the

agency. There is no prefiling review of

the adequacy of data to support a GRAS

conclusion. Thus, the filing of a petition

for GRAS affirmation should not be

interpreted as a preliminary indication

of suitability for GRAS affirmation.

The potential environmental impact

of this action is being reviewed. If the

agency finds that an environmental

impact statement is not required and

this petition results in a regulation, the

notice of availability of the agency’s

finding of no significant impact and the

evidence supporting that finding will be

published with the regulation in the

Federal Register in accordance with 21

CFR 25.40(c).

Interested persons may, on or before

May 20, 1997, review the petition and

file comments with the Dockets

Management Branch (address above).

Two copies of any comments should be

filed and should be identified with the

docket number found in brackets in the

heading of this document. Comments

should include any available

information that would be helpful in

determining whether the substance is,

or is not, GRAS for the proposed use. In

addition, consistent with the regulations

promulgated under the National

Environmental Policy Act (40 CFR

1501.4(b)), the agency encourages public

participation by review of and comment

on the environmental assessment

submitted with the petition that is the

subject of this notice. A copy of the

petition (including the environmental

assessment) and received comments

may be seen in the Dockets Management

Branch between 9 a.m. and 4 p.m.,

Monday through Friday.

Dated: February 12, 1997.

George H. Pauli,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 97–5454 Filed 3–5–97; 8:45 am]

BILLING CODE 4160–01–F

Health Care Financing Administration

[Document Identifier: HCFA–3427]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration.

In compliance with the Paperwork

Reduction Act of 1995 (44 U.S.C. 3501

et seq.), the Health Care Financing

Administration (HCFA), Department of

Health and Human Services, has

submitted to the Office of Management

and Budget (OMB) the following

proposals for the collection of

information. Interested persons are

invited to send comments regarding the

burden estimate or any other aspect of

this collection of information, including

any of the following subjects: (1) the

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Reinstatement, with change, of

previously approved collection for

which approval has expired; Title of

Information Collection: End Stage Renal

Disease (ESRD) Application and Survey

and Certification Report Form; Form

No.: HCFA–3427; Use: This form is a

facility identification and screening

measurement tool used to initiate the

certification and recertification of ESRD